Caricamento in corso... Attendere.

Profilo società

Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.

Fonte: Cofisem - Ultimo aggiornamento: 13 Mar 2025
Dirigenti principali
Chief Executive Officer Rafael Padilla
Chief Financial Officer Karin Jong
Chief Operating Officer Vera Bakker
Head of Investor Relations Karen Berg
General Counsel Johan Verlinden
Fonte: Cofisem - Ultimo aggiornamento: 13 Mar 2025
Dati principali
Millenium 2024 2023 2022 2021 2020
Net sales 871.960 762.991 683.881 573.808 555.971
Income from ordinary activities 871.960 762.991 683.881 573.808 555.971
Operating income 130.696 108.633 97.909 87.438 88.738
Cost of financial indebtedness net 17.438 15.156 10.620 8.006 13.549
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income 81.001 71.044 70.066 61.379 60.037
Net income (Group share) 80.554 70.547 69.612 61.004 59.601
Fiscal year end 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards IFRS IFRS IFRS IFRS IFRS
Fonte: Cofisem - Ultimo aggiornamento: 13 Mar 2025
Informazioni sull’azionariato
The Goldman Sachs Group, Inc. 18,04 %
AOC Pharma S.à.r.l. 11,06 %
Mawer Investment Management Ltd. 5,02 %
Alychlo NV 4,97 %
FMR LLC 4,51 %
Fonte: Cofisem - Ultimo aggiornamento: 13 Mar 2025

Indirizzo

Fagron N.V.

Venecoweg 20A
BE-9810 Nazareth
Belgium
Fonte: Cofisem - Ultimo aggiornamento: 13 Mar 2025

Contatto

Karen Berg
Telefono: +31 88 33 11 288
Fonte: Fagron N.V. - Ultimo aggiornamento: 13 Mar 2025